APA (7th ed.) Citation

Daisho, T., Kagami, K., Yamazaki, K., Ishiguro, N., Endo, T., Takahata, M., . . . Takekuma, Y. (2023). Therapeutic drug monitoring-enabled long-term use of linezolid for the successful treatment of refractory pyogenic spondylodiscitis without development of thrombocytopenia: A case report. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 28(6), 1587-1591. https://doi.org/10.1016/j.jos.2021.11.018

Chicago Style (17th ed.) Citation

Daisho, Takayuki, Keisuke Kagami, Koujiro Yamazaki, Nobuhisa Ishiguro, Tsutomu Endo, Masahiko Takahata, Hisataka Suzuki, Mitsuru Sugawara, and Yoh Takekuma. "Therapeutic Drug Monitoring-enabled Long-term Use of Linezolid for the Successful Treatment of Refractory Pyogenic Spondylodiscitis Without Development of Thrombocytopenia: A Case Report." Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association 28, no. 6 (2023): 1587-1591. https://doi.org/10.1016/j.jos.2021.11.018.

MLA (9th ed.) Citation

Daisho, Takayuki, et al. "Therapeutic Drug Monitoring-enabled Long-term Use of Linezolid for the Successful Treatment of Refractory Pyogenic Spondylodiscitis Without Development of Thrombocytopenia: A Case Report." Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association, vol. 28, no. 6, 2023, pp. 1587-1591, https://doi.org/10.1016/j.jos.2021.11.018.